Fluorescent Dyes for Lymph Node Mapping

Completed · Phase 1

Conditions studied: Breast Cancer

In brief

The goal of this clinical research study is to find lymph nodes before surgery using a dye called indocyanine green (IC-Green). Objectives: 1. To determine the feasibility of using nonradioactive optical imaging techniques with indocyanine green (ICG) as a fluorescent contrast agent to identify all axillary lymph nodes. 2. To determine the feasibility of using nonradioactive optical imaging techniques with ICG as a fluorescent contrast agent to characterize lymphatic architecture and function in women with breast cancer who are scheduled for axillary node dissection.

Key facts

Study ID

NCT01095913

Run by

M.D. Anderson Cancer Center

People needed

30

Starts

2010-03-01

Expected to finish

2014-01-01

Last updated by the study team

2015-01-08

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Subjects must be 18 years of age or older
• Diagnosis of breast cancer requiring axillary nodal dissection
• Negative urine pregnancy test within 72 hours prior to study drug administration, if female of childbearing potential
• Females of childbearing potential who agree to use a medically accepted method of contraception for a period of one month following the study. Medically acceptable contraceptives include (i) hormonal contraceptives (such as birth control pills, Depo-Provera, or Lupron Depot) if such use is approved by the subject's Oncologist; (ii) barrier methods (such as a condom or diaphragm) used with a spermicide, or (iii) an intrauterine device (IUD).
• Continuation of Inclusion #4: Non-childbearing potential is defined as physiologically incapable of becoming pregnant, including any female who is post-menopausal; postmenopausal is defined as the time after which a woman has experienced 12 consecutive months of amenorrhea (lack of menstruation).
• Patients with a positive fine needle aspirate or core biopsy of their axillary nodes

You may not qualify if…

• Women who are pregnant or breast-feeding
• Persons who are allergic to iodine
• A female of child-bearing potential who does not agree to use an approved contraceptive for one month after study participation
• History of ipsilateral axillary surgery including sentinel node biopsy
• Any patient who does not meet inclusion criteria for study

Where it is running

• University of Texas Health Science Center - Houston — Houston, Texas, United States
• University of Texas MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.